CN102755252A - New dual-chamber transfusion bag for packaging amino acid and glucose injection - Google Patents
New dual-chamber transfusion bag for packaging amino acid and glucose injection Download PDFInfo
- Publication number
- CN102755252A CN102755252A CN2012102646866A CN201210264686A CN102755252A CN 102755252 A CN102755252 A CN 102755252A CN 2012102646866 A CN2012102646866 A CN 2012102646866A CN 201210264686 A CN201210264686 A CN 201210264686A CN 102755252 A CN102755252 A CN 102755252A
- Authority
- CN
- China
- Prior art keywords
- double
- transfusion bag
- chamber transfusion
- chamber
- bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The invention belongs to the technical field of medicines, and in particular relates to a triple-layer co-extrusion dual-chamber transfusion bag. The dual-chamber transfusion bag is prepared by heat seal; a peelable separate is formed by cold solder joint between two chambers through a special hot press method, the separate plays a role in separating liquid medicines in the two chambers when the liquid medicines are stored and transferred, and the separate can be conveniently opened by applying a certain pressure, so that the two chambers are communicated, and the liquid medicines in the two chambers are mixed. According to the dual-chamber transfusion bag, mixing misoperation which easily occurs when general infusions are mixed can be avoided, particles generated by puncture and cross infection in mixing and the like can be reduced, the transfusion stability can be improved, and the infusion packaged by the dual-chamber bag is in accordance with the requirement of safe, quick and convenient transfusion treatment clinically.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of three-layer co-extruded double-chamber transfusion bag that is used to pack the aminoacid glucose injection.
Background technology
Since 1931 had had venous transfusion, infusion treatment had become one of common, the most general clinical therapeutic modality.The infusion solutions packaged form mainly passed through in development with the next stage: the vial infusion solutions---plastic bottle infusion solutions---PVC big soft infusion bag---non-PVC-soft-bag infusion solutions.Three-layer co-extruded double-chamber transfusion bag is exactly the usually said soft bag of immediate dispensing infusion.
Can open easily in order to ensure the sealing of rosin joint in sterilization and the storage transportation and when using; Requirement to packaging material, production equipment and technology is very high; How to guarantee that product rosin joint in storage, transportation does not ftracture; Can open rosin joint and apply suitable pressure before use, make the medicament mixed of two chambers become a major criterion weighing the double-chamber transfusion bag quality.
Present total parenteral nutrition transfusion all is that different types of transfusion is filled in the big mixed bag generally; Generally have operating room, can reduce the probability of pollution, but can not guarantee thoroughly that medicinal liquid is not contaminated in Grade III Class A hospital; But in basic hospital, generally do not possess mixing condition; Can increase the pollution probability during preparation, have the drug safety problem, cofabrication process is loaded down with trivial details.
The gastrointestinal procedures patient is because the influence of factors such as operation wound, the preceding inspection of art, intestinal preparation and the early stage fasting of postoperative; Postoperative regular meeting causes protein and heat malnutrition; Therefore postoperative in time replenishes an amount of aminoacid, glucose and electrolyte, supplies with for nitrogen that guarantees body and energy, keeps the stable and organ function of organismic internal environment; Reduce the generation of post-operative complication, promote that wound healing is significant.
Enforcement of the present invention can make things convenient for clinical use, reduces and pollutes probability, improves the quality stability of aminoacid glucose injection.
Summary of the invention
Clinical for ease use; Reduce and pollute probability and the stability of improving infusion preparation; The invention provides the double-chamber transfusion bag of the new packing aminoacid glucose injection of a kind of new packing, it is characterized in that: comprise 2 compartments (1) and compartment (2), between 2 compartments, having at interval, (3) separate it; 2 compartments respectively have the path (4) of a perfusion fluid; One side compartment (1) is through path (4) perfusion 500 ml solns, and opposite side compartment (2) is through path (4) perfusion 500 ml solns, and path (4) is parallel with interval (3).
When using clinically, face, the rosin joint at interval (3) is opened, 2 compartments (1) and compartment (2) are connected, thereby the solution of two Room is mixed with the preceding extruding transfusion bag of passing through.
Above-mentioned double-chamber transfusion bag, its main body is processed through hot pressing by three-layer co-extruded film for transfusion, and in the wherein three-layer co-extruded film for transfusion, outer membrane is made up of polypropylene, styrene-ethylene-butylene copolymer; Mesopelagic layer is made up of polypropylene, polyethylene, styrene-ethylene-butylene copolymer; Inner layer film is made up of polypropylene, styrene-ethylene-butylene copolymer.
The main body of above-mentioned double-chamber transfusion bag is processed through hot pressing by three-layer co-extruded film for transfusion, and wherein co-squeeze film for transfusion derives from the three-layer co-extruded film for transfusion product (registration certificate number: advance medicated bag word J20060015) of PolyCineGmbH company customization.
Above-mentioned double-chamber transfusion bag; Wherein said transfusion bag is processed through hot-press method, and between two compartments, forms (3) at interval through the heating rosin joint, and the width of its interval (3) is 0.3-2.0 centimetre; Be preferably 0.5-2.0 centimetre, more preferably 0.8-1.5 centimetre.
Above-mentioned double-chamber transfusion bag; In the wherein said hot-press method, the parameter of rosin joint is: temperature 120-130 ℃, and 0.1-3 second weld interval; The parameter of welded is: temperature 130-160 ℃; 0.1-3 second weld interval, path (4) with the welding parameter of compartment (1), (2) is: temperature 130-160 ℃, and 0.1-3 second weld interval; In the preferred hot-press method; The parameter of rosin joint is: temperature 120-130 ℃; 0.5-2 second weld interval, the parameter of welded is: temperature 130-160 ℃, and 0.5-2.5 second weld interval; The welding parameter of path (4) and compartment (1), (2) is: temperature 130-160 ℃, and 1.0-2.5 second weld interval.
Above-mentioned double-chamber transfusion bag, wherein the real weldering position intensity of double-chamber transfusion bag is measured according to the method for complex pocket in the heat sealing strength algoscopy (YBB00122003), and the meansigma methods at real weldering position all is not less than 25N/15mm; Rosin joint position intensity is measured according to the method for complex pocket in the heat sealing strength algoscopy (YBB00122003), and the meansigma methods at rosin joint position is 5-20N/15mm.
Preferably, the meansigma methods of rosin joint position heat sealing strength is 5-8N/15mm;
Preferably, the meansigma methods of rosin joint position heat sealing strength is 8-12N/15mm;
Preferably, the meansigma methods of rosin joint position heat sealing strength is 12-20N/15mm.
The transverse width of the outer margin contour of above-mentioned double-chamber transfusion bag is 25-30 centimetre, and the longitudinal length of outer margin contour is 25-40 centimetre.
Above-mentioned double-chamber transfusion bag is characterized in that also having an outer packaging bag that it is sealed in the outside of said double-chamber transfusion bag.
Above-mentioned double-chamber transfusion bag, the material that it is characterized in that said outer packaging bag is metal or plastics.
A kind of in green, blue, red, black or the clear, colorless of above-mentioned double-chamber transfusion bag, the color that it is characterized in that said outer packaging bag.
The composition of the aminoacid glucose injection that the present invention relates to comprises:
During clinical use with 2 bags of mixing, through intravenous drip to patient's administration.
The sterilization method of above-mentioned double-chamber transfusion bag adopts the heating means sterilization.
Full nutrition transfusion contains each seed amino acid, glucose and various electrolyte, and wherein Mei Lade (Maillard) reaction can take place for glucose and tryptophan, and compatibility is unstable.The key of double-chamber transfusion bag is a rosin joint, and this rosin joint is strict when depositing usually isolates two chambers, and under certain external force, is opening when using, and two Room are communicated.Linear change does not take place with external force with regard to requiring its material mechanical character in this, and strip of paper used for sealing generally should be identical with packaging material, so adopt non-PVC composite membrane just to become optimum selection.
When clinical transfusion is treated; Usually can 1-3 kind medicine be added in the basic transfusion; And in process for preparation, because of puncture with mix and the transfusion physicochemical property to be changed all can produce a large amount of particulate matters, microgranule gets into and can stop up blood capillary behind the human body and form thrombosis and granuloma; Process for preparation also mispairing and germ contamination might occur, increases nursing staff's labor intensity, increases to have the dangerous pricking wound occurrence probability of latent infection, is unfavorable for nursing staff's occupational safety; And process for preparation is consuming time, is unfavorable for patient's first aid medication.Of the present invention pair of microgranule or because the pollution risk that medicament mixed causes that the chamber bag can reduce to cause because of puncture effectively.
What above technology obtained is qualified two chambers bag, can medicinal liquid be filled into respectively in 2 compartments then, and the sealing of jumping a queue, heat sterilization, both.Double-chamber transfusion bag of the present invention adopts the outer packaging bag of metal or plastic material to seal, and remains in cleaning, ventilation.Double-chamber transfusion bag steady quality of the present invention, meet clinically safety, rapidly, be convenient to use requirement, the infusion treatment when especially being fit to wartime, disaster also is beneficial to the drug safety that guarantees the medical condition backward areas people, is worth development to be promoted.
Description of drawings
The sketch map of Fig. 1 double-chamber transfusion bag of the present invention
Preparation technology's flow chart of Fig. 2 double-chamber transfusion bag of the present invention
The specific embodiment
For a better understanding of the present invention, further set forth the present invention and advantage thereof through embodiment and experimental evidence below.
The preparation technology of double-chamber transfusion bag of the present invention
*: in the three-layer co-extruded film for transfusion, outer membrane is made up of polypropylene, styrene-ethylene-butylene copolymer; Mesopelagic layer is made up of polypropylene, polyethylene, styrene-ethylene-butylene copolymer; Inner layer film is made up of polypropylene, styrene-ethylene-butylene copolymer.
*: three-layer co-extruded film for transfusion derives from the three-layer co-extruded film for transfusion (registration certificate number: advance medicated bag word J20060015) of PolyCineGmbH company.
Experimental example 1-outward appearance detects
Get each 10 of embodiments of the invention 1-32, face range estimation at the bright place of available light respectively, all transparent, bright and clean, do not have a macroscopic foreign body.Mouth interface tube place does not have crackle, crack, hole, painted embedding thing and deposition of foreign material.
Experimental example 2-differentiates
(1) microscopic features: get each 10 of embodiments of the invention 1-32, be cut into suitable thickness respectively, put microscopically and observe, three layers of cross section clear display.
(2) real weldering intensity: get embodiments of the invention 1-32, measure according to the method for complex pocket in the heat sealing strength algoscopy (YBB00122003) respectively, the meansigma methods at each heat seal position all is not less than 25N/15mm.
(3) rosin joint intensity: get embodiments of the invention 1-32, measure according to the method for complex pocket in the heat sealing strength algoscopy (YBB00122003) respectively, the meansigma methods at each heat seal position is (5N-20N)/15mm.
The experimental example 3-compatibility test of sterilizing
Get each 100 of embodiments of the invention 1-32, difference fill proportioning medicinal liquid, and seal.Adopt moist hear heat test (standard sterilization F
0The value>=8, like 121 ℃ of moist heat sterilizations, 15 minutes) sterilization after, carry out following test:
1. thermal adaptability:
Get 10 in above-mentioned sample; In-25 ℃ ± 2 ℃ condition held 24 hours, under 50 ℃ ± 2 ℃ condition, continue then to place 24 hours, again 23 ℃ ± 2 ℃ condition held 24 hours; At last sample is placed between the two parallel plates; Bear the intrinsic pressure of 67KPa, kept 10 minutes, no liquid spills.
2. anti-drop
Get 10 in above-mentioned sample; In-25 ℃ ± 2 ℃ condition held 24 hours, under 50 ℃ ± 2 ℃ condition, continue then to place 24 hours, again 23 ℃ ± 2 ℃ condition held 24 hours; Press the falling height of table 1 at last; It is fallen respectively on the inflexible smooth surface of a hard, do not break and leak, and the heat-sealing sealing coat does not have breakage.
Table 1 falling height
| Sign capacity (ml) | Falling height (m) |
| 500-500 | ?1.00 |
| 500-500 | ?0.75 |
| 500-500 | ?0.50 |
| 500-500 | ?0.25 |
3. transparency
Get 10 in above-mentioned sample, other gets one in empty bag, and the level number of packing into is No. 4 a turbidity standard, as the contrast bag; Under black background, with 2000lx-3000lx irradiation (avoiding exposure experiment personnel's eyes), visualization can be distinguished with the contrast bag with electric filament lamp.
4. particulate matter
Get 10 in above-mentioned sample; The interval of opening between two chambers is mixed solution; Measure according to the method under infusion bottle and the transfusion bag item in the particulate matter algoscopy (YBB00272004) of packaging material, the population of particle diameter >=5,10,25 μ m is lower than 100,20,2/ml respectively.
5. puncture force
Get 10 of transfusion bag of the present invention; With the perforator that meets disposable infusion set gravity liquid infusing type standard (GB8368-2005); Site of puncture with the speed of 200mm/min ± 20mm/min puncture transfusion bag; The puncture force of plastics perforator is lower than 100N, and the puncture force of metal puncture device is lower than 80N.
The retentivity of perforator and the impermeability of insertion point
Get 10 double-chamber transfusion bags; Firmly extruding opens intermediary rosin joint bar, with meeting disposable infusion set; The insertion point of the perforator puncture transfusion bag of gravity liquid infusing type standard (GB8368-2005); Pull up perforator with the speed of 200mm/min ± 20mm/min then, the separating force of plastics perforator is not less than 5.0N, and the separating force of metal puncture device is not less than 1.0N.After extracting perforator, transfusion bag is placed between the two parallel plates again, apply the intrinsic pressure of 20kpa, kept 15 seconds, the insertion point does not have leak of liquid.
6. the sealing of injection point
Get 10 double-chamber transfusion bags, firmly extruding is opened intermediary rosin joint bar; Use external diameter as the entry needle puncture and injection of medicine point of 0.6mm and kept 15 seconds, extract entry needle after, then bag is placed between the two parallel plates; Apply the intrinsic pressure of 20kpa, kept 15 seconds, injection point does not leak.
7. light transmittance
Get the smooth position of transfusion bag of the present invention; Be cut into the section of 5 0.9cm * 4cm, put into absorption cell along the incident illumination vertical direction respectively, topped up with water; And with water as blank; According to ultraviolet visible spectrophotometry (two appendix IV of Chinese Pharmacopoeia version in 2005 A), measure light transmittance at the 450nm place, all be not less than 75%.
8. residue on ignition
Get 1 of transfusion bag of the present invention, shred, precision takes by weighing 5.0g, places the crucible of constant weight.Be heated to 100 ℃ of dryings 1 hour, and in 550 ℃ of ignition to constant weight, left over residue and be lower than 0.05% again.After getting residue under the residue on ignition item and adding hydrochloric acid (1 → 2) 25ml dissolving, measure according to atomic absorption spectrophotometry (two appendix IV of Chinese Pharmacopoeia version in 2005 D),
Copper is measured in the 324.8nm wavelength, is lower than 3/1000000ths;
Cadmium is measured in the 228.8nm wavelength, is lower than 3/1000000ths;
Chromium is measured in the 357.9nm wavelength, is lower than 3/1000000ths;
Plumbous in 217.0nm wavelength mensuration, be lower than 3/1000000ths;
Stannum is measured in the 286.3nm wavelength, is lower than 3/1000000ths;
Barium is measured in the 553.6nm wavelength, is lower than 3/1000000ths.
The drug release test of experimental example 4-blank transfusion bag of the present invention
Get smooth part (the internal surface area 600cm of the blank transfusion bag (no medicinal liquid is filled) of embodiments of the invention 1-32
2), be cut into the fritter of 5cm * 0.5cm, use water washing, after the drying at room temperature, place the conical flask of 500ml, add water 200ml, sealing is put in the autoclave sterilizer, in 121 ℃ of heating 30 minutes, puts and is chilled to room temperature, as test liquid; Water intaking as blank solution, is carried out following test with the method operation in addition:
1. clarity: get test liquid, measure, the solution clarification according to clarity inspection technique (two appendix IX of Chinese Pharmacopoeia version in 2005 B); As showing muddy, compare with No. 2 turbidity standards, denseer.
2. color: get test liquid, inspection (two appendix IX of Chinese Pharmacopoeia version in 2005 A) in accordance with the law, solution is colourless.
3. foam stability test: get test liquid 5ml, place in the tool plug test tube (internal diameter 15mm, highly about 200mm), shaken 3min, the foam of generation disappears in 3min.
4.pH value: get test liquid 20ml, add Klorvess Liquid (1 → 1000) 1ml, measure according to pH value algoscopy (two appendix VI of Chinese Pharmacopoeia version in 2005 H), pH value is 5.0-7.0.
5. ultraviolet absorptivity: getting test liquid, is contrast with the blank solution.According to ultraviolet visible spectrophotometry (two appendix IV of Chinese Pharmacopoeia version in 2005 A), in the scope interscan of wavelength 220-350nm.Obtained the maximum absorption between 220-240nm is lower than 0.08; Obtained the maximum absorption between 241-350nm is lower than 0.05.
6. non-volatile matter: get test liquid 50ml, put in the evaporating dish of constant weight, water bath method, and be dried to constant weight at 105 ℃.Make blank correction with blank solution, leave over residue and be lower than 2.5mg.
7. readily oxidizable substance: precision is measured test liquid 20ml, and accurate permanganate titration liquid (0.002mol/L) 10ml and the dilution heat of sulfuric acid 10.0ml of adding heats little boiling 3 minutes, is cooled to room temperature.Add the 0.1g potassium iodide, to light brown, add the titration of 5 starch indicator solution continued again to colourless with sodium thiosulfate volumetric solution (0.01mol/L) titration.Carry out blank assay simultaneously, the difference that experimental liquid and blank solution consume volumetric solution is lower than 1.5ml.
8. ammonium ion: get test liquid 50ml, add alkaline test solution of mercuric potassium iodide 2ml, placed 15 minutes; Like colour developing,, add contrast liquor ratio that blank solution 46ml and alkaline test solution of mercuric potassium iodide 2ml process, darker with ammonium chloride solution (get ammonium chloride 31.5mg, add no ammonia and make dissolving in right amount and be diluted to 1000ml) 4.0ml.（0.00008%）
9. barium ions: it is an amount of to get test liquid, measures down according to the metallic element item, be lower than 1,000,000/.
10. copper ion: it is an amount of to get test liquid, measures down according to the metallic element item, be lower than 1,000,000/.
11. cadmium ion: it is an amount of to get test liquid, measures down according to the metallic element item, is lower than 1/10000000th.
12. lead ion: it is an amount of to get test liquid, measures down according to the metallic element item, be lower than 1,000,000/.
13. tin ion: it is an amount of to get test liquid, measures down according to the metallic element item, is lower than 1/10000000th.
14. chromium ion: it is an amount of to get test liquid, measures down according to the metallic element item, be lower than 1,000,000/.
15. aluminium ion: it is an amount of to get test liquid, measures in the wavelength of 309.3nm according to atomic absorption spectrophotometry (two appendix IV of Chinese Pharmacopoeia version in 2005 D), is lower than 1,000,000/zero point zero five.
16. heavy metal: precision is measured test liquid 20ml, adds acetate buffer (pH3.5) 2ml, inspection (two appendix VIII of Chinese Pharmacopoeia version in 2005 H, first method) in accordance with the law, be lower than 1,000,000/.
Experimental example 5-detection of bacterial endotoxin
Get each 10 of the blank transfusion bag of embodiments of the invention 1-32, add the apirogen water of sign capacity, behind the envelope, place autoclave sterilizer, in 121 ℃ ± 2 ℃ sterilizations 30 minutes, put cold, as experimental liquid.Gel method (two appendix XIE of Chinese Pharmacopoeia version in 2005 method 1) according to bacterial endotoxins test is measured, and is lower than 0.25EU/ml.
Experimental example 6-rosin joint detects
The requirement of strength sample of rosin joint in the process of storing transportation except can bearing certain pressure, anti-drop and rosin joint do not ftracture and damages; Also desired strength can not be too big; Clinician or nurse can open the rosin joint extruding with suitable strength, are convenient to the mixing of two chambers bag transfusion, convenient clinical use.
Get each 10 of the blank transfusion bag of embodiments of the invention 1-32, measure according to the method for complex pocket in the heat sealing strength algoscopy (YBB00122003) respectively, the meansigma methods at each heat seal position is 5-20N/15mm.
Wherein, the formulation of rosin joint low intensity limit ensures that according to being anti-drop test data finished product under the commercially available back condition, in loading and unloading and transportation, can not produce damaged situation because of the external force effect; In clinical use, the opening operation of two chambers bag rosin joint makes things convenient for, uses compliance to be foundation well with finished product in the formulation of the rosin joint intensity upper limit.For working out the bound scope of rosin joint intensity, we have designed a series of tests and have drawn reasonable parameter.
Rosin joint low intensity limit EXPERIMENTAL DESIGN: open Bag Making Machine, adjustment heat-seal temperature and slit width are produced a collection of double-chamber transfusion bag; Through the intercepting of rosin joint position being carried out the tensile force test, rosin joint intensity is respectively 3-4N, 5-6N, and each specification bag of each parameter area is no less than 100; Get above-mentioned sample, according to different specifications fill water for injection, after jumping a queue; Sterilising temp according to finished product is sterilized; Get sample after the sterilization in-25 ℃ ± 2 ℃ condition held 24 hours, under 50 ℃ ± 2 ℃ condition, continue then to place 24 hours, again 23 ℃ ± 2 ℃ condition held 24 hours; Whether drop on the inflexible smooth surface of a hard from the height of 0.75m respectively at last, observing double-chamber transfusion bag has and breaks and leak.
Result of the test: rosin joint intensity is the sample of 3-4N, and falling the middle rosin joint in back has generation to squeeze situation about opening, and rosin joint intensity is the sample of 5-6N, not breaks after falling or crowded opening.Considering has certain difference between the different batches film, for guaranteeing in the finished product transportation damaged situation not to take place, the lower limit of rosin joint intensity is decided to be 5N.
Rosin joint heat sealing strength upper limit EXPERIMENTAL DESIGN: open Bag Making Machine, adjustment heat-seal temperature and slit width are produced a collection of double-chamber transfusion bag; Through the intercepting of rosin joint position being carried out the tensile force test, rosin joint intensity is respectively 5-8N, 8-10N, 10-12N, 12-14N, 14-16N; 16-18N, each parameter area bag of 18-20N are no less than 200, get above-mentioned sample, according to different specifications fill water for injection; After jumping a queue, sterilize according to the sterilising temp of finished product, the sample of getting after the sterilization makes an experiment.
Select 10 of female employees at random at workshop, 5 of male employees are divided into 3 groups according to the power of hand strength, every group 5 people, and everyone is no less than 10 bags by the test specimen of getting different rosin joint intensity, with the two chambers of hands extruding bag, sees whether two intermediary rosin joints of chamber bag can be opened.
Result of the test: with strength from weak to strong ordering; Rosin joint intensity is 5-8N, 8-10N, 10-12N, 12-14N, 14-16N, the test specimen of 16-18N, 18-20N; The member of 3 groups all can with the hands push out rosin joint; And showing that with the increasing of rosin joint intensity the operating pressure of opening rosin joint strengthens, difficulty increases.Rosin joint intensity is the test specimen of 18-20N, preceding 2 group memberships had surpass half the strength weak person can not the smooth opening rosin joint, the 3rd group membership opens rosin joint also has certain degree of difficulty.Considering between the film of different batches has certain difference, for convenient clinical use, with being defined as 20N on the rosin joint intensity.
Experimental example 7-outer packaging bag is to the sex investigation of preparation stabilization
Get each 5 of the pastille transfusion finished products of embodiments of the invention 1-32; Under 25 ℃, the condition of relative humidity 45%; Form to adopt or not adopt the outer packaging bag sealing keeps sample, and measures the relative percentage composition of the relatively poor relatively tryptophan of stability, investigates the influence of outer package to preparation stability.
* relatively there were significant differences with no outer packaging bag, and there were significant differences for # and the colourless comparison of non-PVC
Can reach a conclusion through this experiment: outer packaging bag is to being poured in the stability of drug effect of being significantly improved in the double-chamber transfusion bag of the present invention, and coloured outer packaging bag is more obvious to the improvement effect of preparation stability.
Claims (12)
1. the double-chamber transfusion bag of a new packing parenteral nutrition injection; It is characterized in that: comprise 2 compartments (1) and compartment (2); Between 2 compartments, have interval (3) that it is separated, 2 compartments respectively have the path (4) of a perfusion fluid, and a side compartment (1) is through path (4) perfusion 500 ml solns; Opposite side compartment (2) is through path (4) perfusion 500 ml solns, and path (4) is parallel with interval (3).
2. double-chamber transfusion bag according to claim 1; The main body that it is characterized in that said double-chamber transfusion bag is processed through hot pressing by three-layer co-extruded film for transfusion, and it number is the three-layer co-extruded film for transfusion of medicated bag word J20060015 into that wherein three-layer co-extruded film for transfusion derives from PolyCineGmbH certificate of incorporation.
3. according to any described double-chamber transfusion bag of claim 1-2, it is characterized in that having formed rosin joint (3) at interval through hot pressing between said compartment (1) and (2), the width of its interval (3) is 0.3-2.0 centimetre.
4. double-chamber transfusion bag according to claim 3 is characterized in that the width at the interval (3) between its compartment is 0.5-2.0 centimetre.
5. double-chamber transfusion bag according to claim 4 is characterized in that the width at the interval (3) between its compartment is 0.8-1.5 centimetre.
6. according to each described double-chamber transfusion bag of claim 1-5; The real weldering position intensity that it is characterized in that said double-chamber transfusion bag is measured according to the method for complex pocket in the heat sealing strength algoscopy (YBB00122003), and the meansigma methods at each heat seal position all is not less than 25N/15mm; Rosin joint position intensity is measured according to the method for complex pocket in the heat sealing strength algoscopy (YBB00122003), and the meansigma methods at each heat seal position is 5-20N/15mm.
7. double-chamber transfusion bag according to claim 6 is characterized in that the meansigma methods at each heat seal position of said double-chamber transfusion bag is 5-8N/15mm.
8. double-chamber transfusion bag according to claim 6 is characterized in that the meansigma methods at each heat seal position of said double-chamber transfusion bag is 8-12N/15mm.
9. double-chamber transfusion bag according to claim 6 is characterized in that the meansigma methods at each heat seal position of said double-chamber transfusion bag is 12-20N/15mm.
10. according to any described double-chamber transfusion bag of claim 1-2, the transverse width that it is characterized in that the outer margin contour of said double-chamber transfusion bag is 25-30 centimetre, and the longitudinal length of outer margin contour is 25-40 centimetre.
11., it is characterized in that also having an outer packaging bag that it is sealed in the outside of said double-chamber transfusion bag according to any described double-chamber transfusion bag of claim 1-2.
12. a kind of in green, blue, red, black or the clear, colorless of double-chamber transfusion bag according to claim 11, the color that it is characterized in that said outer packaging bag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102646866A CN102755252A (en) | 2011-07-28 | 2012-07-27 | New dual-chamber transfusion bag for packaging amino acid and glucose injection |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110213442.0 | 2011-07-28 | ||
| CN201110213442 | 2011-07-28 | ||
| CN2012102646866A CN102755252A (en) | 2011-07-28 | 2012-07-27 | New dual-chamber transfusion bag for packaging amino acid and glucose injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102755252A true CN102755252A (en) | 2012-10-31 |
Family
ID=47050073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102646866A Pending CN102755252A (en) | 2011-07-28 | 2012-07-27 | New dual-chamber transfusion bag for packaging amino acid and glucose injection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102755252A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110753538A (en) * | 2017-06-05 | 2020-02-04 | 迪兹林制药公司 | Levodopa infusion solutions |
| WO2024045344A1 (en) * | 2022-08-30 | 2024-03-07 | 安徽丰原药业股份有限公司 | Preparation method for cyanide antidote injection |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004081276A (en) * | 2002-08-23 | 2004-03-18 | Otsuka Pharmaceut Factory Inc | Double chamber container for medical treatment |
| CN1630501A (en) * | 2002-02-14 | 2005-06-22 | 株式会社大塚制药工场 | Medical multi-chamber container |
| CN2832145Y (en) * | 2005-05-13 | 2006-11-01 | 湖南千山制药机械股份有限公司 | Infusion bag with one connection tube and parallel double chambers |
| CN2853067Y (en) * | 2005-12-30 | 2007-01-03 | 青岛华仁药业股份有限公司 | Multichamber extrusion instant dispensing plastic transfusion flexible bag |
| US20070144923A1 (en) * | 1999-11-12 | 2007-06-28 | Vincent Houwaert | Peelable seal closure assembly |
| CN102068379A (en) * | 2011-01-19 | 2011-05-25 | 四川科伦药业股份有限公司 | Dual-cavity aseptic bag and manufacturing method thereof |
| CN102406545A (en) * | 2011-12-28 | 2012-04-11 | 四川科伦药业股份有限公司 | Double-cavity bag for containing medicine liquid |
| CN102406544A (en) * | 2011-11-29 | 2012-04-11 | 湖南科伦制药有限公司 | Azithromycin lactobionateinjection solution packaged by double-cavity bag and preparation method |
| CN202314359U (en) * | 2011-07-28 | 2012-07-11 | 辽宁海思科制药有限公司 | Novel double-chamber transfusion bag for packaging amino acid and glucose injection |
-
2012
- 2012-07-27 CN CN2012102646866A patent/CN102755252A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070144923A1 (en) * | 1999-11-12 | 2007-06-28 | Vincent Houwaert | Peelable seal closure assembly |
| CN1630501A (en) * | 2002-02-14 | 2005-06-22 | 株式会社大塚制药工场 | Medical multi-chamber container |
| JP2004081276A (en) * | 2002-08-23 | 2004-03-18 | Otsuka Pharmaceut Factory Inc | Double chamber container for medical treatment |
| CN2832145Y (en) * | 2005-05-13 | 2006-11-01 | 湖南千山制药机械股份有限公司 | Infusion bag with one connection tube and parallel double chambers |
| CN2853067Y (en) * | 2005-12-30 | 2007-01-03 | 青岛华仁药业股份有限公司 | Multichamber extrusion instant dispensing plastic transfusion flexible bag |
| CN102068379A (en) * | 2011-01-19 | 2011-05-25 | 四川科伦药业股份有限公司 | Dual-cavity aseptic bag and manufacturing method thereof |
| CN202314359U (en) * | 2011-07-28 | 2012-07-11 | 辽宁海思科制药有限公司 | Novel double-chamber transfusion bag for packaging amino acid and glucose injection |
| CN102406544A (en) * | 2011-11-29 | 2012-04-11 | 湖南科伦制药有限公司 | Azithromycin lactobionateinjection solution packaged by double-cavity bag and preparation method |
| CN102406545A (en) * | 2011-12-28 | 2012-04-11 | 四川科伦药业股份有限公司 | Double-cavity bag for containing medicine liquid |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110753538A (en) * | 2017-06-05 | 2020-02-04 | 迪兹林制药公司 | Levodopa infusion solutions |
| US11633353B2 (en) | 2017-06-05 | 2023-04-25 | Dizlin Pharmaceuticals Ab | Levodopa infusion solution |
| WO2024045344A1 (en) * | 2022-08-30 | 2024-03-07 | 安徽丰原药业股份有限公司 | Preparation method for cyanide antidote injection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7466579B2 (en) | Perfusion dosage form | |
| BG62847B1 (en) | Elastic container for parenteral fluids and method for its preparation | |
| EP3312006A1 (en) | Multi-layered plastic polymeric container for the storage of pharmaceutical compositions | |
| WO2021184699A1 (en) | Moxifloxacin hydrochloride and sodium chloride injection and preparation method therefor | |
| RU2621144C2 (en) | Pharmaceutical form of gemcitabine of large volume for infusion and kit containing formulations | |
| CN105796370B (en) | Lysotropic liquid crystal precursor and its preparation method and application for root canal disinfection | |
| CN101259137A (en) | Instant matched medical styptic anti-adhesive flush fluid | |
| CN202376453U (en) | Novel package of double-chamber transfusion bag of parenteral nutrition injection | |
| CN102755252A (en) | New dual-chamber transfusion bag for packaging amino acid and glucose injection | |
| CN202314359U (en) | Novel double-chamber transfusion bag for packaging amino acid and glucose injection | |
| CN208389001U (en) | A kind of dual-chamber bag for packing alanyl glutamine and amino acid (18) injection | |
| CN202376452U (en) | Novel three-chamber transfusion bag used for packaging medium-long-chain fat emulsion, 16 amino acids and 16% dextrose injection | |
| CN202314358U (en) | Novel multi-cavity infusion bag for packaging injection liquid | |
| CN104497415B (en) | Infusion bag thermoplastic elastomer (TPE) and preparation method thereof | |
| CN102764194A (en) | Novel double-chamber transfusion bag for packing parenteral nutritional injection | |
| Rojanasakul et al. | Parenteral routes of delivery | |
| JP2001520183A (en) | Solution for peritoneal dialysis and method for producing the same | |
| CN202376451U (en) | Novel three-chamber transfusion bag used for packaging fat emulsion, 17 amino acids and 11% dextrose injections | |
| CN106798749A (en) | A kind of PVP-I film forming sterilizing agent and its preparation method and application | |
| CN102772299A (en) | Novel three-chamber transfusion bag for packaging fat emulsion, amino acid and dextrose injection | |
| JP7021303B2 (en) | How to make a medical bag | |
| Chapman | Parenteral products | |
| JP2000197687A (en) | Medical container and its manufacture | |
| CN102772298A (en) | Novel three-cavity transfusion bag for packaging long-chain fat emulsion injection, amino acid injection and glucose injection | |
| CN105267035A (en) | Novel three-chamber transfusion bag used for packaging Medium- and long-chain fat emulsion, amino acid and glucose injection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121031 |